Literature DB >> 8540653

Inhibition of TNF alpha improves survival in an experimental model of acute pancreatitis.

C B Hughes1, L W Gaber, A B Mohey el-Din, H P Grewal, M Kotb, L Mann, A O Gaber.   

Abstract

The development of systemic complications in acute pancreatitis is largely responsible for the mortality associated with this disease. The systemic sequelae encountered in acute pancreatitis are similar to those occurring in patients with septic shock, a syndrome of multiple organ failure thought to be related to overproduction of inflammatory cytokines. As with sepsis, data is mounting that cytokines, particularly TNF alpha, may play a central role in acute pancreatitis and mediate the systemic sequelae of the disease. We have previously shown elevated levels of TNF alpha in the serum of animals with experimental acute pancreatitis. In this study, we use a bile-infusion model of pancreatitis in the rat to show amelioration of disease severity as well as a distinct survival advantage by TNF alpha blockade using anti-TNF alpha polyclonal antibody. These data provide strong evidence that TNF alpha is a major contributor to the morbidity and mortality from acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8540653

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  23 in total

1.  Effects of time interval for hemofiltration on the prognosis of severe acute pancreatitis.

Authors:  En-Qiang Mao; Yao-Qing Tang; Sheng-Dao Zhang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

2.  Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis.

Authors:  Hong-Li Jiang; Wu-Jun Xue; Da-Qing Li; Ai-Ping Yin; Xia Xin; Chun-Mei Li; Ju-Lin Gao
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

3.  Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis.

Authors:  A S Gukovskaya; I Gukovsky; V Zaninovic; M Song; D Sandoval; S Gukovsky; S J Pandol
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 4.  Acute pancreatitis at the beginning of the 21st century: the state of the art.

Authors:  Alfredo F Tonsi; Matilde Bacchion; Stefano Crippa; Giuseppe Malleo; Claudio Bassi
Journal:  World J Gastroenterol       Date:  2009-06-28       Impact factor: 5.742

Review 5.  Immunomodulatory therapies for acute pancreatitis.

Authors:  Jing Li; Wen-Juan Yang; Lu-Ming Huang; Cheng-Wei Tang
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

6.  Ablation of phosphoinositide 3-kinase-gamma reduces the severity of acute pancreatitis.

Authors:  Enrico Lupia; Alberto Goffi; Paolo De Giuli; Ornella Azzolino; Ornella Bosco; Enrico Patrucco; Maria Cristina Vivaldo; Marco Ricca; Matthias P Wymann; Emilio Hirsch; Giuseppe Montrucchio; Giorgio Emanuelli
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

7.  Polymorphisms in tumour necrosis factor alpha (TNFalpha) gene in patients with acute pancreatitis.

Authors:  Gül Ozhan; Hakan T Yanar; Cemalettin Ertekin; Buket Alpertunga
Journal:  Mediators Inflamm       Date:  2010-04-14       Impact factor: 4.711

8.  Dexamethasone and dextran 40 treatment of 32 patients with severe acute pancreatitis.

Authors:  Zi-Fa Wang; Chang Liu; Yi Lu; Rui Dong; Jun Xu; Liang Yu; Ying-Min Yao; Qing-Guang Liu; Cheng-En Pan
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

9.  Interleukin-10 reduces circulating levels of serum cytokines in experimental pancreatitis.

Authors:  A J Rongione; A M Kusske; H A Reber; S W Ashley; D W McFadden
Journal:  J Gastrointest Surg       Date:  1997 Mar-Apr       Impact factor: 3.452

Review 10.  Pharmacological approach to acute pancreatitis.

Authors:  Ulrich-Christian Bang; Synne Semb; Camilla Nojgaard; Flemming Bendtsen
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.